190 related articles for article (PubMed ID: 16908993)
1. Clinical and molecular aspects of frontotemporal dementia.
Froelich-Fabre S; Skoglund L; Ostojic J; Kilander L; Lindau M; Glaser A; Basun H; Lannfelt L
Neurodegener Dis; 2004; 1(4-5):218-24. PubMed ID: 16908993
[TBL] [Abstract][Full Text] [Related]
2. Frontotemporal dementia.
Graff-Radford NR; Woodruff BK
Semin Neurol; 2007 Feb; 27(1):48-57. PubMed ID: 17226741
[TBL] [Abstract][Full Text] [Related]
3. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
[TBL] [Abstract][Full Text] [Related]
4. Familial frontotemporal dementia: a report of three cases of severe cerebral atrophy with rare inclusions that are negative for tau and synuclein, but positive for ubiquitin.
Chang HT; Cortez S; Vonsattel JP; Stopa EG; Schelper RL
Acta Neuropathol; 2004 Jul; 108(1):10-6. PubMed ID: 15108011
[TBL] [Abstract][Full Text] [Related]
5. Progranulin null mutations in both sporadic and familial frontotemporal dementia.
Le Ber I; van der Zee J; Hannequin D; Gijselinck I; Campion D; Puel M; Laquerrière A; De Pooter T; Camuzat A; Van den Broeck M; Dubois B; Sellal F; Lacomblez L; Vercelletto M; Thomas-Antérion C; Michel BF; Golfier V; Didic M; Salachas F; Duyckaerts C; Cruts M; Verpillat P; Van Broeckhoven C; Brice A;
Hum Mutat; 2007 Sep; 28(9):846-55. PubMed ID: 17436289
[TBL] [Abstract][Full Text] [Related]
6. Frontotemporal dementia--a brief review.
Sjögren M; Andersen C
Mech Ageing Dev; 2006 Feb; 127(2):180-7. PubMed ID: 16330083
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.
Forno LS; Langston JW; Herrick MK; Wilson JD; Murayama S
Acta Neuropathol; 2002 Jun; 103(6):599-606. PubMed ID: 12012092
[TBL] [Abstract][Full Text] [Related]
8. Frontotemporal dementia--Part II. Differential diagnosis, genetics, molecular pathomechanism and pathology.
Galariotis V; Bódi N; Janka Z; Kálmán J
Ideggyogy Sz; 2005 Jul; 58(7-8):220-4. PubMed ID: 16173270
[TBL] [Abstract][Full Text] [Related]
9. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22.
Rosso SM; Kamphorst W; de Graaf B; Willemsen R; Ravid R; Niermeijer MF; Spillantini MG; Heutink P; van Swieten JC
Brain; 2001 Oct; 124(Pt 10):1948-57. PubMed ID: 11571213
[TBL] [Abstract][Full Text] [Related]
10. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions.
Kertesz A; Kawarai T; Rogaeva E; St George-Hyslop P; Poorkaj P; Bird TD; Munoz DG
Neurology; 2000 Feb; 54(4):818-27. PubMed ID: 10690970
[TBL] [Abstract][Full Text] [Related]
11. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.
Taniguchi S; McDonagh AM; Pickering-Brown SM; Umeda Y; Iwatsubo T; Hasegawa M; Mann DM
Neuropathol Appl Neurobiol; 2004 Feb; 30(1):1-18. PubMed ID: 14720172
[TBL] [Abstract][Full Text] [Related]
12. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases.
Mackenzie IR; Feldman H
Acta Neuropathol; 2003 Jun; 105(6):543-8. PubMed ID: 12734660
[TBL] [Abstract][Full Text] [Related]
13. Distinct genetic forms of frontotemporal dementia.
Seelaar H; Kamphorst W; Rosso SM; Azmani A; Masdjedi R; de Koning I; Maat-Kievit JA; Anar B; Donker Kaat L; Breedveld GJ; Dooijes D; Rozemuller JM; Bronner IF; Rizzu P; van Swieten JC
Neurology; 2008 Oct; 71(16):1220-6. PubMed ID: 18703462
[TBL] [Abstract][Full Text] [Related]
14. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases.
Mackenzie IR; Feldman H
Dement Geriatr Cogn Disord; 2004; 17(4):333-6. PubMed ID: 15178948
[TBL] [Abstract][Full Text] [Related]
15. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval.
Rademakers R; Cruts M; Dermaut B; Sleegers K; Rosso SM; Van den Broeck M; Backhovens H; van Swieten J; van Duijn CM; Van Broeckhoven C
Mol Psychiatry; 2002; 7(10):1064-74. PubMed ID: 12476321
[TBL] [Abstract][Full Text] [Related]
16. Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.
Rosso SM; van Herpen E; Pijnenburg YA; Schoonenboom NS; Scheltens P; Heutink P; van Swieten JC
Arch Neurol; 2003 Sep; 60(9):1209-13. PubMed ID: 12975285
[TBL] [Abstract][Full Text] [Related]
17. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.
Wilhelmsen KC; Forman MS; Rosen HJ; Alving LI; Goldman J; Feiger J; Lee JV; Segall SK; Kramer JH; Lomen-Hoerth C; Rankin KP; Johnson J; Feiler HS; Weiner MW; Lee VM; Trojanowski JQ; Miller BL
Arch Neurol; 2004 Mar; 61(3):398-406. PubMed ID: 15023818
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of frontotemporal dementia.
Neumann M; Tolnay M; Mackenzie IR
Expert Rev Mol Med; 2009 Jul; 11():e23. PubMed ID: 19638255
[TBL] [Abstract][Full Text] [Related]
19. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
20. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
